Joseph W Kim

79 posts

Joseph W Kim

Joseph W Kim

@Joseph_W_Kim

GU medical oncologist and Clinical Trialist. Specialize in #Genitourinary Cancers #Immunotherapy and #Targeted Therapies. All tweets and comments are my own.

New Haven, CT Katılım Eylül 2017
188 Takip Edilen205 Takipçiler
Joseph W Kim retweetledi
AACR
AACR@AACR·
.@AACR_CEO Margaret Foti announces the launch of the AACR Trailblazer Cancer Research Grants—which will provide nine $1 million grants to early-stage investigators and six $1 million grants to mid-career investigators—at the #AACR25 Opening Ceremony.
AACR tweet media
English
0
17
59
6.2K
Joseph W Kim retweetledi
FDA Oncology
FDA Oncology@FDAOncology·
Today, FDA Oncology Center Director Richard Pazdur, MD, accepted the @AACR 2025 Enduring Impact Award for Transformative Service to Cancer Science and Medicine from his former mentee, AACR President Dr. Patricia LoRusso, during the #AACR25 Annual Meeting Opening Ceremony.
FDA Oncology tweet mediaFDA Oncology tweet mediaFDA Oncology tweet mediaFDA Oncology tweet media
English
0
8
22
3.2K
Joseph W Kim retweetledi
Ravi A Madan M.D.
Ravi A Madan M.D.@Dr_RaviMadan·
As someone who worked with and (more importantly) learned from Mary @nciccr_gmb @NCIResearchCtr I am so happy to see that she is still inspiring excellence in oncology patient care. 🙏🏽
JADPRO@JADPRO

Do you know an advanced practitioner who demonstrates exemplary leadership and outstanding contributions in the field of #oncology? The @APSHOorg Mary Pazdur Award for Excellence in Advanced Practice in Oncology nomination period is open! Learn more here: marypazduraward.com

English
2
3
8
1.2K
Joseph W Kim retweetledi
AACR
AACR@AACR·
AACR members have elected Patricia M. LoRusso, DO, PhD (hc), as their 2023-2024 President-Elect. Dr. LoRusso will become President-Elect on April 17 during the #AACR23 Business Meeting of Members and will assume the Presidency during #AACR24. @YaleCancer @SmilowCancer
AACR tweet media
English
5
35
151
51.5K
Joseph W Kim
Joseph W Kim@Joseph_W_Kim·
@DrEricWiner @AACR @YaleCancer @SmilowCancer Pat always brings new energy, insights from her years of experience, and new creative ideas to transform how we do our clinical trials that are patient-centered and how we materialize and execute “ideas” into Research and Practice.
English
0
0
4
150
Eric Winer, MD
Eric Winer, MD@DrEricWiner·
Yale Cancer Center is filled with pride that Pat LoRusso is a nominee for @AACR president, with ballot opening today. We are all 100% behind her, and I know she will be an extraordinary leader for AACR. @YaleCancer @SmilowCancer
English
9
31
183
28.1K
Joseph W Kim retweetledi
Ravi A Madan M.D.
Ravi A Madan M.D.@Dr_RaviMadan·
You are never too early or late in your training to say thank you and have mutual respect. Care for Oncology patients is a team sport and our patients need and deserve the best teams we’ve got. Thanks @ClayReedMD @theNCI
Clay Reed, MD@ClayReedMD

Something that always stood out to me in training was when the attending/consultant would go out of their way to thank the trainees for their hard work. @acgreenlund @Dr_RaviMadan - much appreciated! #MedTwitter

English
0
1
8
981
Joseph W Kim retweetledi
Prostate Cancer Foundation
Prostate Cancer Foundation@PCFnews·
We're excited to welcome William K. Oh, MD, an internationally recognized genitourinary (GU) oncologist with expertise in the use of systemic treatments for prostate cancer, has been appointed Chief Medical Officer (CMO). bit.ly/3GllP93
Prostate Cancer Foundation tweet media
English
1
2
18
0
Joseph W Kim
Joseph W Kim@Joseph_W_Kim·
2/2, our study showed olaparib + cediranib improved median rPFS by 4.5 months with over olaparib alone with an HR=0.62. But it was associated with increased toxicity. Consistent with other reports, BRCA2 seems to be the most reliable biomarker of benefit. Check out our manuscript
English
0
1
9
0

Keşfet

@AACR_CEO @AACR @nciccr_gmb @TheLancetOncol @BladderCancerUS @YaleCancer @SmilowCancer @BraunMDPhD